Bioengineering Improves Adeno-Associated Virus Vector for Gene Therapy
A new study characterizes a bioengineered adeno-associated virus (AAV)3B capsid variant that demonstrates improved transduction to human liver cells
Bioengineering Improves Adeno-Associated Virus Vector for Gene Therapy
